Cytotoxic T lymphocyte-associated antigen 4 blockade with ipilimumab: Long-term follow-up of 179 patients with metastatic melanoma.

8544 Background: We have previously shown objective clinical responses in patients with metastatic melanoma treated with CTLA-4 blockadeusing ipilimumab. We have treated 179 patients in 3 separate...